111 related articles for article (PubMed ID: 26226845)
1. Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma.
Sun W; Chatterjee B; Wang Y; Stevenson HS; Edelman DC; Meltzer PS; Barr FG
Mod Pathol; 2015 Sep; 28(9):1214-24. PubMed ID: 26226845
[TBL] [Abstract][Full Text] [Related]
2. Rhabdomyosarcoma: current challenges and their implications for developing therapies.
Hettmer S; Li Z; Billin AN; Barr FG; Cornelison DD; Ehrlich AR; Guttridge DC; Hayes-Jordan A; Helman LJ; Houghton PJ; Khan J; Langenau DM; Linardic CM; Pal R; Partridge TA; Pavlath GK; Rota R; Schäfer BW; Shipley J; Stillman B; Wexler LH; Wagers AJ; Keller C
Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a025650. PubMed ID: 25368019
[TBL] [Abstract][Full Text] [Related]
3. Functional Genomics of Novel Rhabdomyosarcoma Fusion-Oncogenes Using Zebrafish.
Kent MR; Silvius K; Kucinski J; Calderon D; Kendall GC
Methods Mol Biol; 2024; 2707():23-41. PubMed ID: 37668903
[TBL] [Abstract][Full Text] [Related]
4. Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining.
Zhan X; Liu Y; Jannu AJ; Huang S; Ye B; Wei W; Pandya PH; Ye X; Pollok KE; Renbarger JL; Huang K; Zhang J
Front Oncol; 2023; 13():1080989. PubMed ID: 36793601
[TBL] [Abstract][Full Text] [Related]
5. New Dual Inducible Cellular Model to Investigate Temporal Control of Oncogenic Cooperating Genes.
Kent MR; Jay AN; Kendall GC
bioRxiv; 2024 Feb; ():. PubMed ID: 38464002
[TBL] [Abstract][Full Text] [Related]
6. A Bayesian model for identifying cancer subtypes from paired methylation profiles.
Fan Y; S Chan A; Zhu J; Yi Leung S; Fan X
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36575828
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in molecular profiling of bone and soft tissue tumors.
Baumhoer D; Hench J; Amary F
Skeletal Radiol; 2024 Jan; ():. PubMed ID: 38231260
[TBL] [Abstract][Full Text] [Related]
8. Role of CD73 and the purinergic signaling pathway in the pathogenesis of fusion-negative rhabdomyosarcoma.
Fascì A; Deaglio S
Purinergic Signal; 2024 May; ():. PubMed ID: 38700722
[No Abstract] [Full Text] [Related]
9. PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma.
Pandey PR; Chatterjee B; Olanich ME; Khan J; Miettinen MM; Hewitt SM; Barr FG
J Pathol; 2017 Apr; 241(5):626-637. PubMed ID: 28138962
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups.
Oberlin O; Rey A; Brown KL; Bisogno G; Koscielniak E; Stevens MC; Hawkins DS; Meyer WH; La TH; Carli M; Anderson JR
Pediatr Blood Cancer; 2015 Dec; 62(12):2125-31. PubMed ID: 26257045
[TBL] [Abstract][Full Text] [Related]
11. Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation.
Sun M; Huang F; Yu D; Zhang Y; Xu H; Zhang L; Li L; Dong L; Guo L; Wang S
Cell Death Dis; 2015 Aug; 6(8):e1859. PubMed ID: 26291313
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of Childhood Sarcomas.
Roberts SS; Chou AJ; Cheung NK
Front Oncol; 2015; 5():181. PubMed ID: 26301204
[TBL] [Abstract][Full Text] [Related]
13. Rhabdomyosarcoma of the head and neck in children: review and update.
Reilly BK; Kim A; Peña MT; Dong TA; Rossi C; Murnick JG; Choi SS
Int J Pediatr Otorhinolaryngol; 2015 Sep; 79(9):1477-83. PubMed ID: 26231745
[TBL] [Abstract][Full Text] [Related]
14. TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.
Zhu B; Zhang M; Williams EM; Keller C; Mansoor A; Davie JK
Oncogene; 2016 Aug; 35(32):4212-24. PubMed ID: 26686089
[TBL] [Abstract][Full Text] [Related]
15. MyoD transcription factor induces myogenesis by inhibiting Twist-1 through miR-206.
Koutalianos D; Koutsoulidou A; Mastroyiannopoulos NP; Furling D; Phylactou LA
J Cell Sci; 2015 Oct; 128(19):3631-45. PubMed ID: 26272918
[TBL] [Abstract][Full Text] [Related]
16. Subsequent Neoplasms in Adult Survivors of Childhood Genitourinary Tumors.
Johnston DL; Bishop MW; Hudson MM; Giel DW
Urology; 2015 Oct; 86(4):666-75. PubMed ID: 26232689
[TBL] [Abstract][Full Text] [Related]
17. Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma.
Sun W; Chatterjee B; Shern JF; Patidar R; Song Y; Wang Y; Walker RL; Pawel BR; Linardic CM; Houghton P; Hewitt SM; Edelman DC; Khan J; Meltzer PS; Barr FG
Int J Cancer; 2019 Jun; 144(11):2707-2717. PubMed ID: 30565669
[TBL] [Abstract][Full Text] [Related]
18. PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.
Gryder BE; Yohe ME; Chou HC; Zhang X; Marques J; Wachtel M; Schaefer B; Sen N; Song Y; Gualtieri A; Pomella S; Rota R; Cleveland A; Wen X; Sindiri S; Wei JS; Barr FG; Das S; Andresson T; Guha R; Lal-Nag M; Ferrer M; Shern JF; Zhao K; Thomas CJ; Khan J
Cancer Discov; 2017 Aug; 7(8):884-899. PubMed ID: 28446439
[TBL] [Abstract][Full Text] [Related]
19. MYOD1 as a prognostic indicator in rhabdomyosarcoma.
Ahmed AA; Habeebu S; Farooqi MS; Gamis AS; Gonzalez E; Flatt T; Sherman A; Surrey L; Arnold MA; Conces M; Koo S; Dioufa N; Barr FG; Tsokos MG
Pediatr Blood Cancer; 2021 Sep; 68(9):e29085. PubMed ID: 33913590
[TBL] [Abstract][Full Text] [Related]
20. Rhabdomyosarcoma.
Skapek SX; Ferrari A; Gupta AA; Lupo PJ; Butler E; Shipley J; Barr FG; Hawkins DS
Nat Rev Dis Primers; 2019 Jan; 5(1):1. PubMed ID: 30617281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
